Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLA1 | P09884 | 1/20 | 0.76 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.74 |
| ▸ | OSBP | P22059 | 3/20 | 0.70 |
| ▸ | USP2 | O75604 | 2/20 | 0.70 |
| ▸ | RORC | P51449 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.70 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.70 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.62 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.60 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.60 |
| ▸ | GBA1 | P04062 | 2/20 | 0.59 |
| ▸ | UGCG | Q16739 | 2/20 | 0.59 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.59 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8840044 | 1.00 | POLA1 (0.76) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL16425693 | 0.97 | POLA1 (0.74) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL10379193 | 0.97 | POLA1 (0.74) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL10379191 | 0.97 | POLA1 (0.74) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL10379190 | 0.97 | POLA1 (0.74) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL5327347 | 0.97 | POLA1 (0.74) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL19598930 | 0.96 | POLA1 (0.72) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL3213813 | 0.96 | POLA1 (0.72) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL3213821 | 0.96 | POLA1 (0.72) | POLA1CYP46A1OSBPUSP2RORC | |
| SCHEMBL27833162 | 0.96 | POLA1 (0.72) | POLA1CYP46A1OSBPUSP2RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107652987-B | Preparation method of maleic acid cholesterol monoester group citric acid triester liquid crystal | 太原理工大学 | 2020-06-23 | — | — | CN | claimed |
| CN-107652987-A | The preparation method of maleic acid cholesterol monoesters base citric acid three ester liquid crystal | 太原理工大学 | 2018-02-02 | — | — | CN | claimed |
| WO-2007143173-A2 | ATHEROGENIC COMPOSITIONS AND ANIMAL MODELS OF VASCULAR LESIONS | THE METHODIST HOSPITAL RESEARCH INSTITUTE (US) | 2007-12-13 | — | — | WO | claimed |
| WO-1990006775-A1 | A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS | LIPOSOME TECHNOLOGY, INC. (US) | 1990-06-28 | — | — | WO | claimed |
| US-4602003-A | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia | MEDICAL RESEARCH FOUNDATION OF OREGON (US) | 1986-07-22 | — | — | US | claimed |
| CN-107652987-B | Preparation method of maleic acid cholesterol monoester group citric acid triester liquid crystal | 太原理工大学 | 2020-06-23 | — | — | CN | disclosed |
| CN-107652987-B | Preparation method of maleic acid cholesterol monoester group citric acid triester liquid crystal | 太原理工大学 | 2020-06-23 | — | — | CN | disclosed |
| CN-107652987-B | Preparation method of maleic acid cholesterol monoester group citric acid triester liquid crystal | 太原理工大学 | 2020-06-23 | — | — | CN | disclosed |
| US-10279050-B2 | Sucrose ester based cationic gene vector and preparation method thereof | DALIAN NATIONALITIES UNIVERSITY (CN) | 2019-05-07 | — | — | US | disclosed |
| CN-105985386-B | A kind of sucrose ester type cationic gene carriers and preparation method thereof | 大连民族学院 | 2018-06-26 | — | — | CN | disclosed |
| CN-107652987-A | The preparation method of maleic acid cholesterol monoesters base citric acid three ester liquid crystal | 太原理工大学 | 2018-02-02 | — | — | CN | disclosed |
| CN-107652987-A | The preparation method of maleic acid cholesterol monoesters base citric acid three ester liquid crystal | 太原理工大学 | 2018-02-02 | — | — | CN | disclosed |
| CN-107652987-A | The preparation method of maleic acid cholesterol monoesters base citric acid three ester liquid crystal | 太原理工大学 | 2018-02-02 | — | — | CN | disclosed |
| US-20170326255-A1 | SUCROSE ESTER BASED CATIONIC GENE VECTOR AND PREPARATION METHOD THEREOF | DALIAN NATIONALITIES UNIVERSITY (CN) | 2017-11-16 | — | — | US | disclosed |
| CN-105985386-A | Sucrose ester-type cation genetic vector and preparation method thereof | 大连民族学院 | 2016-10-05 | — | — | CN | disclosed |
| WO-2007143173-A2 | ATHEROGENIC COMPOSITIONS AND ANIMAL MODELS OF VASCULAR LESIONS | THE METHODIST HOSPITAL RESEARCH INSTITUTE (US) | 2007-12-13 | — | — | WO | disclosed |
| US-5593691-A | DIESTERS AND UNSATURATED DIESTERS WITH COSMETICS, DRUGS AND TENSIDES | MARIGEN S.A. (CH) | 1997-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170326255-A1 | SUCROSE ESTER BASED CATIONIC GENE VECTOR AND PREPARATION METHOD THEREOF | CETP, NPC1L1, LIPA | POLA1 1339/4885CYP46A1 216/4885OSBP 830/4885 |
| US-10279050-B2 | Sucrose ester based cationic gene vector and preparation method thereof | CETP, NPC1L1, LIPA | POLA1 1339/4885CYP46A1 216/4885OSBP 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.